Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics

Publisher Name :
Date: 01-Jan-2019
No. of pages: 108

Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics

Summary

GBI Research's latest report: "Biosimilars" provides an in-depth assessment of the current developments and trends in the global biosimilars market. This report also assesses the state of the biosimilar R&D and commercial landscape through multilevel analytics that include data split by therapy area, stage of development, molecule, and company. Global revenue forecasts to 2024 for biosimilars with strong market potential, both in development and in the market, are provided.

Data analyses from our study shows that there will be enormous commercial opportunities for biosimilar manufacturers over the coming years, given the number of high-revenue-generating biologics that will go off patent in the next five years, and promising revenue forecasts for biosimilars in late-stage development.

Information leveraged from our robust industry-leading database highlights a diverse number of biosimilars in the pipeline for a wide range of therapy areas, with several of these in the later stages of development. Government support for biosimilars is increasing in key mature and emerging markets, given the cost-saving opportunities that these products represent for national healthcare budgets.

Our study details current biosimilar regulatory frameworks and guidelines implemented in the US, Europe, Japan, China, South Korea, India and Brazil, and recent developments in the landscape within these markets. GBI Research conducted extensive research efforts in order to provide a comprehensive view of the global biosimilar market. This new report adds to our unique portfolio of trusted industry analyses that enable our clients to assess the most promising commercial areas in the market and exploit key business opportunities.

Scope

- How does the global biosimilar pipeline look like in 2018?

- What is the distribution of pipeline biosimilars by stage of development?

- Which are the therapy areas set to benefit the most from biosimilar drugs in development?

- Which biosimilars are commonly targeted in the pipeline?

- How many companies are currently involved in biosimilar drug development? Which are the most active in the pipeline?

- What is the size of the global biosimilar market?

- How much revenue will promising biosimilar drugs in the market, and in development, record to 2024?

- What are the key factors driving growth in the global biosimilars market?

- What are the factors restraining the growth of global biosimilar market?

- How does legislation regarding biosimilar interchangeability differ among key geographical markets?

- How will legal or political changes in the landscape affect the biosimilar market?

- What are the key differences in biosimilar regulatory pathways between US, Europe, Japan, South Korea, China, Brazil, and India?

- What are the regulatory evidence requirements in each country?

Reasons to buy

- Develop an overview of the current biosimilar landscape in key markets

- Learn how regulatory or legal changes will affect the market

- Identify market prospects

Global Biosimilars Market - Increasingly Lucrative Market Fueled by Constrained Payer Environment and Patent Expiries for Best-Selling Biologics

1 Table of Contents
EXECUTIVE SUMMARY
INTRODUCTION
2.1 Defining Biosimilars
2.2 Comparative Analysis: Biosimilars vs Generics
2.3 Biobetters
2.4 Why Biosimilars? SWOT Analysis
KEY DRIVERS
3.1 Constrained Payer Environment
3.2 Cost-effectiveness
3.3 Patent expiration
KEY BARRIERS
4.1 Development complexities and cost
4.2 Strategies from originators
4.3 Interchangeability and substitution concerns
BIOSIMILARS IN MATURE MARKETS
5.1 Biosimilar Approval Pathways Across Key Mature Markets
5.2 Biosimilars in EU
5.2.1 Developments in the EU Biosimilar Landscape: Gainsharing
5.3 Biosimilars in the US
5.3.1 Developments in the US Biosimilar Landscape: Reimbursement
5.3.2 Developments in the US Biosimilar Landscape: Rebate
5.4 Biosimilars in Japan
BIOSIMILARS IN EMERGING MARKET
6.1 Biosimilar Approval Pathways Across Key Emerging Markets
6.2 Biosimilars in South Korea
6.3 Biosimilars in China
6.3.1 Developments in the Chinese Biosimilar Landscape: Reforms
6.3.2 Developments in the Chinese Biosimilar Landscape: Investments
6.4 Biosimilars in Brazil
6.5 Biosimilars in India
6.6 Strategies for Biosimilars Manufacturers in Emerging Markets
GLOBAL BIOSIMILAR PIPELINE ANALYSIS
7.1 Global Biosimilar Pipeline by Stage of Development
7.2 Global Biosimilar Pipeline by Therapy Area
7.3 Global Biosimilar Pipeline by Indication: Top 10 targeted indications
7.4 Global Biosimilar Pipeline by Molecule: Top 10 targeted biosimilars
7.5 Most Active Manufacturers in the Global Biosimilar Pipeline: Product Volume by Stage of Development
7.6 Most Active Manufacturers in the Global Biosimilar Pipeline: Product Volume by Molecule
7.7 Most Active Manufacturers in the Global Biosimilar Late Stage Pipeline
GLOBAL BIOSIMILAR MARKET AND PRODUCT SALES FORECAST
8.1 Global Rituximab Biosimilar Market Forecast 2017 - 2024
8.2 Rituximab Biosimilar Market: ABP 798 Global Sales Forecast 2017 - 2024
8.3 Global Infliximab Biosimilar Market Forecast 2017 - 2024
8.4 Infliximab Biosimilar Market: Inflectra Global Sales Forecast 2017 - 2024
8.5 Global Trastuzumab Biosimilar Market Forecast 2017 - 2024
8.6 Trastuzumab Biosimilar Market: Kanjinti Global Sales Forecast 2017 - 2024
8.7 Global Bevacizumab Biosimilar Market Forecast 2017 - 2024
8.8 Bevacizumab Biosimilar Market: Mvasi Global Sales Forecast 2017 - 2024
8.9 Global Adalimumab Biosimilar Market Forecast 2017 - 2024
8.10 Adalimumab Biosimilar Market: Global Imraldi Sales Forecast 2017 - 2024
8.11 Insulin Glargine Biosimilar Market: Basaglar Global Sales Forecast 2017 - 2024
8.12 Etanercept Biosimilar Market: Benepali Global Sales Forecast 2017 - 2024
STRATEGIC ALLIANCES
9.1 Global Biosimilar Partnership Deals by Region and Value
9.2 Global Biosimilars Partnership Deals by Year
9.3 Global Biosimilar Licensing Deals by Region and Value
9.4 Global Biosimilar Licensing Deals by Year
9.5 Top 10 Targeted Biosimilars in Strategic Alliances
9.6 Most Active Companies in Strategic Alliances
COMPANY PROFILE
10.1 Sandoz
10.2 Pfizer
10.3 Celltrion
10.4 Samsung Bioepis
10.5 Amgen
10.6 Biocon
10.7 Dr. Reddy's Laboratories
BIBLIOGRAPHY
Disclaimer
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs